Elizabeth S. Levy

989 total citations
21 papers, 587 citations indexed

About

Elizabeth S. Levy is a scholar working on Oncology, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Elizabeth S. Levy has authored 21 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Materials Chemistry and 4 papers in Molecular Biology. Recurrent topics in Elizabeth S. Levy's work include Nanoparticle-Based Drug Delivery (4 papers), Luminescence Properties of Advanced Materials (3 papers) and Quantum Dots Synthesis And Properties (2 papers). Elizabeth S. Levy is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Luminescence Properties of Advanced Materials (3 papers) and Quantum Dots Synthesis And Properties (2 papers). Elizabeth S. Levy collaborates with scholars based in United States, France and Japan. Elizabeth S. Levy's co-authors include Emory M. Chan, Bruce E. Cohen, P. James Schuck, Peter C. Ford, Tejal A. Desai, Cheryl Tajon, Ángel Fernández-Bravo, Jillian Iafrati, Maysamreza Chamanzar and Thomas S. Bischof and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth S. Levy

20 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth S. Levy United States 13 316 209 137 122 57 21 587
Marius Hossu United States 13 423 1.3× 334 1.6× 92 0.7× 97 0.8× 58 1.0× 16 671
Paul J. Derry United States 17 360 1.1× 242 1.2× 319 2.3× 74 0.6× 170 3.0× 33 950
Nima Sayyadi Australia 13 249 0.8× 241 1.2× 279 2.0× 126 1.0× 42 0.7× 25 757
Shuangshuang He China 13 238 0.8× 158 0.8× 304 2.2× 115 0.9× 252 4.4× 37 789
Yung‐Chieh Chan Taiwan 13 487 1.5× 381 1.8× 163 1.2× 74 0.6× 76 1.3× 24 802
Pengpeng Cao China 18 313 1.0× 131 0.6× 97 0.7× 46 0.4× 44 0.8× 23 566
Takashi Harimoto Japan 12 332 1.1× 369 1.8× 97 0.7× 69 0.6× 31 0.5× 30 737
Liuen Liang Australia 11 426 1.3× 378 1.8× 135 1.0× 88 0.7× 80 1.4× 20 692
John V. Garcia United States 9 296 0.9× 309 1.5× 196 1.4× 32 0.3× 47 0.8× 11 556
Xinwen Liu China 15 275 0.9× 102 0.5× 426 3.1× 151 1.2× 14 0.2× 49 837

Countries citing papers authored by Elizabeth S. Levy

Since Specialization
Citations

This map shows the geographic impact of Elizabeth S. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth S. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth S. Levy more than expected).

Fields of papers citing papers by Elizabeth S. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth S. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth S. Levy. The network helps show where Elizabeth S. Levy may publish in the future.

Co-authorship network of co-authors of Elizabeth S. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth S. Levy. A scholar is included among the top collaborators of Elizabeth S. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth S. Levy. Elizabeth S. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Shijia, Elizabeth S. Levy, Nanzhi Zang, et al.. (2024). Scaling laws for nanoparticles – Online shape heterogeneity analysis by size exclusion chromatography coupled with multi-angle light scattering. Journal of Chromatography A. 1736. 465386–465386. 1 indexed citations
2.
An, Le, Tom De Bruyn, Jodie Pang, et al.. (2024). Early Stage Preclinical Formulation Strategies to Alter the Pharmacokinetic Profile of Two Small Molecule Therapeutics. Pharmaceuticals. 17(2). 179–179. 1 indexed citations
3.
Zhang, Donglu, Bin Ma, Peter S. Dragovich, et al.. (2024). Tissue distribution and retention drives efficacy of rapidly clearing VHL-based PROTACs. SHILAP Revista de lepidopterología. 4(1). 87–87. 8 indexed citations
4.
Levy, Elizabeth S., An D. Nguyen, Donglu Zhang, et al.. (2023). Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs. Pharmaceutics. 15(8). 2098–2098. 12 indexed citations
5.
Latham, Andrew P., Elizabeth S. Levy, Benjamin D. Sellers, & Dennis Leung. (2023). Utilizing Molecular Simulations to Examine Nanosuspension Stability. Pharmaceutics. 16(1). 50–50. 4 indexed citations
6.
Levy, Elizabeth S., Evan Werlin, Mian Chen, et al.. (2023). Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries. SHILAP Revista de lepidopterología. 4. 100126–100126. 6 indexed citations
7.
Levy, Elizabeth S., Alberto Estevez, Jialin Mao, et al.. (2021). A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology. The AAPS Journal. 23(6). 111–111. 20 indexed citations
8.
Fan, Yuchen, Elizabeth S. Levy, Nanzhi Zang, et al.. (2021). Fast and versatile analysis of liposome encapsulation efficiency by nanoParticle exclusion chromatography. Journal of Chromatography A. 1662. 462688–462688. 33 indexed citations
9.
Levy, Elizabeth S., Ryan Chang, Colin R. Zamecnik, et al.. (2021). Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity. Molecular Pharmaceutics. 18(3). 1014–1025. 16 indexed citations
10.
Zamecnik, Colin R., Elizabeth S. Levy, Margaret M. Lowe, et al.. (2019). An Injectable Cytokine Trap for Local Treatment of Autoimmune Disease. Biomaterials. 230. 119626–119626. 19 indexed citations
11.
Levy, Elizabeth S., et al.. (2019). Human intestinal spheroids cultured using Sacrificial Micromolding as a model system for studying drug transport. Scientific Reports. 9(1). 9936–9936. 30 indexed citations
12.
Levy, Elizabeth S., et al.. (2019). Reversible inhibition of efflux transporters by hydrogel microdevices. European Journal of Pharmaceutics and Biopharmaceutics. 145. 76–84. 13 indexed citations
13.
Chan, Emory M., Christian Monachon, Nicholas J. Borys, et al.. (2016). Far-field optical nanothermometry using individual sub-50 nm upconverting nanoparticles. Nanoscale. 8(22). 11611–11616. 30 indexed citations
14.
Levy, Elizabeth S., Cheryl Tajon, Thomas S. Bischof, et al.. (2016). Energy-Looping Nanoparticles: Harnessing Excited-State Absorption for Deep-Tissue Imaging. ACS Nano. 10(9). 8423–8433. 134 indexed citations
15.
Levy, Elizabeth S., Demosthenes Morales, John V. Garcia, Norbert O. Reich, & Peter C. Ford. (2015). Near-IR mediated intracellular uncaging of NO from cell targeted hollow gold nanoparticles. Chemical Communications. 51(100). 17692–17695. 38 indexed citations
16.
Chan, Emory M., Elizabeth S. Levy, & Bruce E. Cohen. (2015). Rationally Designed Energy Transfer in Upconverting Nanoparticles. Advanced Materials. 27(38). 5753–5761. 138 indexed citations
17.
DeMartino, Anthony W., et al.. (2013). Photocatalytic Carbon Disulfide Production via Charge Transfer Quenching of Quantum Dots. Journal of the American Chemical Society. 136(6). 2192–2195. 45 indexed citations
18.
Levy, Elizabeth S., et al.. (2004). Voluntary Facility-Level Sustainability Performance Reporting: Current Status, Relationship to Organization-Level Reporting, and Principles for Progress. Pace Environmental Law Review. 21(2). 265–265. 1 indexed citations
19.
Awwad, Eric E., et al.. (1995). Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement.. American Journal of Neuroradiology. 16(8). 1719–20. 35 indexed citations
20.
Levy, Elizabeth S., et al.. (1977). [Malignant evolution of Kaposi's sarcoma with impaired cellular immunity].. PubMed. 93(9). 242–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marius Hossu Breakdown of academic impact, for papers by Paul J. Derry Breakdown of academic impact, for papers by Nima Sayyadi Breakdown of academic impact, for papers by Shuangshuang He Breakdown of academic impact, for papers by Yung‐Chieh Chan Breakdown of academic impact, for papers by Pengpeng Cao Breakdown of academic impact, for papers by Takashi Harimoto Breakdown of academic impact, for papers by Liuen Liang Breakdown of academic impact, for papers by John V. Garcia Breakdown of academic impact, for papers by Xinwen Liu
Rankless by CCL
2026